NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes.
We demonstrate in 351 diabetic patients with steatosis that NAFLD fibrosis score (NFS), a rapid and affordable score to diagnose hepatic fibrosis, identifies patients at higher risk of advanced fibrosis and vascular diabetic complications (especially peripheral neuropathy), pointing NFS as a first-line vascular and hepatic screening in diabetic patients.
['Lombardi|Rosa|R|', 'Airaghi|Lorena|L|', 'Targher|Giovanni|G|', 'Serviddio|Gaetano|G|', 'Maffi|Gabriele|G|', 'Mantovani|Alessandro|A|', 'Maffeis|Claudio|C|', 'Colecchia|Antonio|A|', 'Villani|Rosanna|R|', 'Rinaldi|Luca|L|', 'Orsi|Emanuela|E|', 'Pisano|Giuseppina|G|', 'Adinolfi|Luigi Elio|LE|', 'Fargion|Silvia|S|', 'Fracanzani|Anna Ludovica|AL|']
D000553:Ambulatory Care D002318:Cardiovascular Diseases D003924:Diabetes Mellitus, Type 2 D006801:Humans D008103:Liver Cirrhosis D065626:Non-alcoholic Fatty Liver Disease
NAFLD Diabetic neuropathy Microvascular complications Non-invasive diagnosis Stroke Type 2 diabetes screening